Reliability And Validity Of Urdu Version Of Boston Carpal Tunnel Syndrome Questionnaire

Sponsor
Riphah International University (Other)
Overall Status
Completed
CT.gov ID
NCT05207566
Collaborator
(none)
110
1
9
12.2

Study Details

Study Description

Brief Summary

Translate and culturally adapt Boston Carpal Tunnel Syndrome Questionnaire into Urdu language and find its reliability and validity in Pakistani Carpal Tunnel Syndrome patients To check its correlation with Disabilities of the Arm, Shoulder and Hand questionnaire and Visual Analog Scale.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The original version of Boston Carpal Tunnel Syndrome Questionnaire will be translated into Urdu. Among idiopathic Carpal Tunnel Syndrome, 110 patients will be included in the study by convenience sampling. The selection of the patients will be done according to the criteria. Boston Carpal Tunnel Syndrome Questionnaire will be correlated with Disabilities of the Arm, Shoulder and Hand questionnaire and Visual Analog Scale and these questionnaires will be provided three times to a single patient for their assessment. Firstly, they will be provided prior to treatment and secondly just after having treatment. Thirdly, they will be given after seven days of treatment. Internal consistency and reproducibility will be used to determine reliability. Boston Carpal Tunnel Syndrome Questionnaire will be correlated with Disabilities of the Arm, Shoulder and Hand questionnaire and Visual Analog Scale to assess validity. From each patient informed consent will be obtained. Statistical Package of Social Sciences software, version 24 will be used for the analysis of data.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    110 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    Psychometric Properties of Urdu Version of Boston Carpal Tunnel Syndrome Questionnaire : A Reliability and Validity Study
    Actual Study Start Date :
    May 30, 2021
    Actual Primary Completion Date :
    Feb 25, 2022
    Actual Study Completion Date :
    Feb 28, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Boston Carpal Tunnel Syndrome Questionnaire [1st day]

      Boston Carpal Tunnel Syndrome Questionnaireconsists of 2 subscales i.e: symptom severity & functional status.The former contains 11 items for assessing several symptoms while later contains 8 items of daily functional activities. Every item consists of 5 point score with 1 meaning no difficulty while 5 refers to severe symptoms. Boston Carpal Tunnel Syndrome Questionnaire is a short questionnaire and is completed within ten minutes

    2. Disabilities of the Arm, Shoulder and Hand questionnaire [1st day]

      Disabilities of the Arm, Shoulder and Hand questionnaire was developed for use in problems like musculoskeletal in upper limbs. It has been translated into various languages. It consists of 30 items used to assess physical and psychosocial aspects. Every items consists of 5 point score with 1 meaning no difficulty while 5 refers to unable

    3. Visual Analog Scale [1st day]

      VAS is used to evaluate pain and consists of a scale with 0 to 10 readings (0 meaning no pain and 10 meanings unbearable pain).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age equal to or above 18 years.

    • Absence of any cognitive impairment.

    • Patients having positive Tinel and Phalen test.

    Exclusion Criteria:

    Presence of any of following conditions.

    • Diabetes

    • Polyneuropathy

    • Hypothyroidsm

    • Rheumatoid arthritis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ripah International University Faisalabad Punjab Pakistan 38000

    Sponsors and Collaborators

    • Riphah International University

    Investigators

    • Study Chair: Muhammad Kashif, Riphah International University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Riphah International University
    ClinicalTrials.gov Identifier:
    NCT05207566
    Other Study ID Numbers:
    • REC/FSD/0292
    First Posted:
    Jan 26, 2022
    Last Update Posted:
    Jul 6, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Riphah International University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 6, 2022